Media Center

Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting Rocaltrol® City Tour·Beijing Station On July 20, 2023, the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City Tour” jointly organized by…

Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting Rocaltrol® City Tour·Hangzhou Station On July 15, 2023, the fourth stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City…

Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting Rocaltrol® City Tour·Fuzhou Station On June 18, 2023, the third stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City…

Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting Rocaltrol® City Tour·Ji‘nan Station On June 13, 2023, the second stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City…

Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting  Rocaltrol® City Tour·Shanghai Station On June 7, 2023, the first event of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) Interpretation Meeting and Rocaltrol® City…

Pharmanovia & Hesenna Lishui inspection report From May 23rd to 24th, 2023, the British pharmaceutical company Pharmanovia came to Lishui, known as the “Zhejiang Green Valley”, to conduct a two-day on-site inspection and meetings with Zhejiang Hesenna Medicine Co., Ltd.…

On April 13, 2023, Pharmanovia and Zhejiang Hesenna Medicine (hereinafter referred to as Hesenna) held a strategic cooperation conference and “Leaping Tiger” project (Rocaltrol) launch ceremony. Ian McAleer, General Manager of Pharmanovia China, and Mr. Gu, Chairman of Hesenna, signed…

Hesenna (GuangDong) Health Consulting Co., Ltd. has mature business operation capabilities and experience, based on professional and academic, has a professional team, data analysis-driven operation model and compliance with global standards. With the operation of RLD (Reference Listed Drug) bondronat®, we have established…

On December 29, 2020, “Health Intelligence Medicine,The World Gathering Lishui”, a  investment promotion meeting of 100 listed pharmaceutical companies was held in Lishui. Liu Zhiwei, the member of the party group of Lishui Municipal Government, secretary of the Party Working Committee of Lishui…